chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Nasal congestion, Pyrexia
Clinical narrative: Low grade fever (100.0F); stuffy nose; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 30Apr2021 at 15:30 (at the age of 17-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included tretinoin (MANUFACTURER UNKNOWN) and fluticasone propionate (MANUFACTURER UNKNOWN); both for unknown indications from unknown dates. The patient past drug therapy included azithromycin (MANUFACTURER UNKNOWN) taken for unknown indication on unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 09Apr2021 at 15:30 (at the age of 17-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Apr2021 at 21:00, the patient experienced Low grade fever (100.0F), stuffy nose and tiredness. The patient underwent lab tests and procedures that included body temperature on 30Apr2021 at 21:00, and the result was 100.0 degree Fahrenheit. The clinical outcome of the events low grade fever (100.0F), stuffy nose and tiredness was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperphagia, Hypoglycaemia, Pain
Clinical narrative: Aches; Headache; Severe hypoglycemia; Waking at night with hypoglycemia and need to eat; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6200) via an unspecified route of administration in the right arm on 22Mar2021 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and hypothyroidism. Concomitant medications included levothyroxine sodium (SYNTHROID), valsartan (VALSARTAN), atenolol (MANUFACTURER UNKNOWN), night I'll and acetom. The patient previously received bactrim, fluoroquinones, soy, tomatoes, strawberry, pineapple and legumes. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6198) via an unspecified route of administration in the right arm on 26Feb2021 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 15:00, 24 hours after second shot, the patient experienced aches, headache that lasted for 24 hours. Then severe hypoglycemia for 24 hours. Since 23Mar2021 the patient experienced hypoglycemia two hours after eating that lasts until she eats again. She has even been waking at night with hypoglycemia and need to eat. She has never had a meal after she fell asleep until this past month. The adverse events resulted in a doctor or other healthcare professional office or clinic visit. The clinical outcome of the events aches, headache, severe hypoglycemia and waking at night with hypoglycemia and need to eat was resolved with sequelae at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: first day of period was on February 9 and then second menstrual cycle came at March 18 which is almost 9 days late.; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9262) via an unspecified route of administration on 20Jan2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9266) via an unspecified route of administration on 22Feb2021 (both at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient experienced delayed menstruation. Menstrual cycle has always been regular but ever since the patient got the COVID-19 Pfizer vaccine it has changed dramatically. The patient usually gets period every month regularly may be 2-3 days late but last first day of menstrual cycle was on 18Mar2021 and it was 03May2021 and still did not get menstrual cycle. The patient was not pregnant and did not have sex or engage in sexual activities. The month before that, first day of period was on 09Feb2021 and this was first period after first COVID-19 vaccine and then second menstrual cycle came on 18Mar2021 which is almost 9 days late. Since 18Mar2021, still have not gotten period (16 days late). This all began after getting the COVID-19 vaccine shots. The clinical outcome of the event delayed menstruation was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Dyspnoea, Headache
Clinical narrative: Fever of 103.0; Vomiting; Chills; weakness; shortness of breath; intense headache; lingering headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 10Apr2021 at 11:15 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included escitalopram (MANUFACTURER UNKNOWN) for an unknown indication from unknown date. The past drug history was reported as latex and peanuts. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 20Mar2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 05:00, the patient experienced fever of 103.0, vomiting, chills, weakness, shortness of breath, intense headache and had lingering headache for a week after. The patient underwent lab tests and procedures which included body temperature on 11Apr2021 and resulted as 103.0 (units unspecified).  The clinical outcome of the events fever, vomiting, chills, weakness, shortness of breath and headache were recovered with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fever of 103.0; Vomiting; Chills; weakness; shortness of breath; intense headache; lingering headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 10Apr2021 at 11:15 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included escitalopram (MANUFACTURER UNKNOWN) for an unknown indication from unknown date. The past drug history was reported as latex and peanuts. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 20Mar2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 05:00, the patient experienced fever of 103.0, vomiting, chills, weakness, shortness of breath, intense headache and had lingering headache for a week after. The patient underwent lab tests and procedures which included body temperature on 11Apr2021 and resulted as 103.0 (units unspecified).  The clinical outcome of the events fever, vomiting, chills, weakness, shortness of breath and headache were recovered with sequelae on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWOO158) via an unspecified route of administration in the arm left on 21Apr2021 at 13:15(at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. Concomitant medications included acetylsalicylic acid (ASPIRIN), insulin lispro (HUMALOG) and melatonin (MANUFACTURER UNKNOWN) from unknown dates for unknown indication. The patient previously took Sulfa and penicillin. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Apr2021 the patient experienced Developed Shingles. Therapeutic measures included treatment with An antiviral drug prescription- Valtrex. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event Developed Shingles was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Hyperhidrosis, Nausea
Clinical narrative: Chills; Sweats; Heart palpitations; Weight loss; Dull headache; Nausea; Diarrhea; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 28Apr2021 at 13:45 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included osteoporosis and colitis. Concomitant medications included calcium (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN); both for an unknown indication from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date at 09:15 (age at vaccination not known), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 03:00, the patient experienced body aches, weight loss, dull headache, nausea and diarrhea. On 30Apr2021, patient experienced chills, sweats and heart palpitations (day 2). The patient had body aches for 3 days, dull headache for 3-4 days, chills/sweats starting 48 hours later lasting for 24 hours, nausea for 2 days and diarrhea for 3 days. The clinical outcome of the event chills, sweating and nausea resolved on 01May2021. The clinical outcome of general body pain and diarrhea resolved on 02May2021. The clinical outcome of headache dull was resolved on an unknown date in May2021. The clinical outcome of weight loss and palpitation were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations, Weight decreased
Clinical narrative: Chills; Sweats; Heart palpitations; Weight loss; Dull headache; Nausea; Diarrhea; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 28Apr2021 at 13:45 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included osteoporosis and colitis. Concomitant medications included calcium (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN); both for an unknown indication from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date at 09:15 (age at vaccination not known), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 03:00, the patient experienced body aches, weight loss, dull headache, nausea and diarrhea. On 30Apr2021, patient experienced chills, sweats and heart palpitations (day 2). The patient had body aches for 3 days, dull headache for 3-4 days, chills/sweats starting 48 hours later lasting for 24 hours, nausea for 2 days and diarrhea for 3 days. The clinical outcome of the event chills, sweating and nausea resolved on 01May2021. The clinical outcome of general body pain and diarrhea resolved on 02May2021. The clinical outcome of headache dull was resolved on an unknown date in May2021. The clinical outcome of weight loss and palpitation were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Joint pain; Fever; Injection site swelling; Feeling unwell; Difficulty breathing; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the arm left on an unknown date in 2021 (at the age of 49-year-old) and the patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0175) via an unspecified route of administration in the arm left on 26Apr2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00, the patient experienced dizziness, difficulty breathing, injection site pain (vaccination site pain), tiredness, headache, muscle pain, joint pain, fever, injection site swelling (vaccination site swelling) and feeling unwell. The clinical outcome of the events dizziness, difficulty breathing, injection site pain (vaccination site pain), tiredness, headache, muscle pain, joint pain, fever, injection site swelling (vaccination site swelling) and feeling unwell were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pyrexia, Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Joint pain; Fever; Injection site swelling; Feeling unwell; Difficulty breathing; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the arm left on an unknown date in 2021 (at the age of 49-year-old) and the patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0175) via an unspecified route of administration in the arm left on 26Apr2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00, the patient experienced dizziness, difficulty breathing, injection site pain (vaccination site pain), tiredness, headache, muscle pain, joint pain, fever, injection site swelling (vaccination site swelling) and feeling unwell. The clinical outcome of the events dizziness, difficulty breathing, injection site pain (vaccination site pain), tiredness, headache, muscle pain, joint pain, fever, injection site swelling (vaccination site swelling) and feeling unwell were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash erythematous
Clinical narrative: Shingles on my left upper abdomen; Red Rash with bumbs that are consistent with Shingles; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL0015E) via an unspecified route of administration in the left arm on 24Apr2021 at 14:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included bee stings. Concomitant medications included protein power and herbal tea. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ELO151) via an unspecified route of administration in the left arm on 03Apr2021 at 10:15(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Apr2021 at 12:00, the patient experienced red rash with bumps that are consistent with shingles. The patient reported that his dermatologist believes that he had shingles on left upper abdomen. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit. The patient received treatment for the reported events which included valtrex. The clinical outcome of the event shingles and red rash with bumbs was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hormone level abnormal, Migraine, Muscular weakness, Night sweats
Clinical narrative: Severe migraines; Hormone fluctuations; Brain fog; Muscle weakness; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 50-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 at 11:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 25Mar2021 at 11:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 23:00 i.e. three days after the second dose, the patient experienced severe migraines, started experiencing night sweats, hormone fluctuations, brain fog and muscle weakness. This was still on going 10 days post vaccine. The clinical outcome of the events severe migraines, hormone fluctuations, brain fog, muscle weakness and night sweats were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03May2021 at 09:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medication was not reported. The patient previously took cipro and strawberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 15:00 the patient experienced sore arm. The clinical outcome of the event sore arm was recovering at the time of report..   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Large Bruising  on right leg calf and left forearm.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER731) via an unspecified route of administration in the right arm on 03Apr2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, trigeminal neuralgia, bludge dish, asthma and lower back arthritis started on an unknown date. The patient previously received acetyl salicylic acid (ASPIRIN), amoxicillin (MANUFACTURER UNKNOWN), trea nuts (MANUFACTURER UNKNOWN) and gabapentin (MANUFACTURER UNKNOWN) all for an unknown indication and from an unknown date. Concomitant medications included duloxetine hydrochloride (CYMBALTA), paracetamol (TYLENOL), multi-vitamins (MANUFACTURER UNKNOWN) and fish oil (MANUFACTURER UNKNOWN) all for an unknown indication and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the right arm on an unknown date in Apr2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation,  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 the patient experienced large bruising on right leg calf and left forearm and smaller patches on side of right leg just appeared. No trauma to either area. The patient had doctor or other healthcare professional office or clinic visit due to the adverse events. The patient received treatment for adverse event which included physical and blood work up. The clinical outcome of the event large bruising on right leg calf and left forearm was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Headache, Pain, Pyrexia, Tremor
Clinical narrative: bone pain; severe body aches; Fever; headache; shaking; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Apr2021 at 18:15 (at an unknown age) as a single dose for COVID-19 immunisation. Medical history included was not reported. Patients had no past drug history. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 18:15 (at an unknown age) as a single dose for COVID-19 immunisation. Patient did not taken any concomitant  medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 02:00, the patient experienced fever, headache, severe body aches, bone pain and shaking. The clinical outcome of the events of fever, headache, general body pain, bone pain and shaking were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Limb discomfort, Pain in extremity, Swelling
Clinical narrative: Swelling in left armpit and it is painful; Continues mild pain and feels heavy/left arm is feeling heavy; Swelling in left armpit and it is painful; soreness at the left arm where took vaccine; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 02May2021 at 08:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Patient medical history was provided as no. Patient past drug history was provided as no. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 11Apr2021 at 08:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03May2021 at 11:00, the patient experienced swelling in left armpit and it was painful. The patient also stated that left arm was heavy and there was soreness at the left arm where the patient had vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling in left armpit, it was painful/armpit pain, and left arm was heavy and there was soreness at the left arm were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vaccination site mass, Vaccination site swelling
Clinical narrative: Swelling in left armpit and it is painful; Continues mild pain and feels heavy/left arm is feeling heavy; Swelling in left armpit and it is painful; soreness at the left arm where took vaccine; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 02May2021 at 08:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Patient medical history was provided as no. Patient past drug history was provided as no. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 11Apr2021 at 08:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03May2021 at 11:00, the patient experienced swelling in left armpit and it was painful. The patient also stated that left arm was heavy and there was soreness at the left arm where the patient had vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling in left armpit, it was painful/armpit pain, and left arm was heavy and there was soreness at the left arm were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Decreased appetite, Fatigue
Clinical narrative: Loss of appetite; Coughing; High fever (104); chills for over a day; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EW0175) via an unspecified route of administration in the left arm on 02May2021 at 11:30 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EW0158) via an unspecified route of administration in the left arm on 11Apr2021 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 02May2021 at 16:00, the patient experienced high fever (104 degrees), chills, loss of appetite, fatigue and coughing. The patient underwent lab tests and procedures which included body temperature on 02May2021 and resulted as 104 degrees (units unspecified). The clinical outcome of the events fever, chills, loss of appetite, fatigue and coughing was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Loss of appetite; Coughing; High fever (104); chills for over a day; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EW0175) via an unspecified route of administration in the left arm on 02May2021 at 11:30 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EW0158) via an unspecified route of administration in the left arm on 11Apr2021 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 02May2021 at 16:00, the patient experienced high fever (104 degrees), chills, loss of appetite, fatigue and coughing. The patient underwent lab tests and procedures which included body temperature on 02May2021 and resulted as 104 degrees (units unspecified). The clinical outcome of the events fever, chills, loss of appetite, fatigue and coughing was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscle spasms, Polymenorrhoea, Pyrexia
Clinical narrative: Possible early menstruation / Early period started today; Experienced severe cramps; Fatigue; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 28Apr2021 at 14:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, IBS (irritable bowel syndrome), migraine and year-round respiratory allergies. Concomitant medications included liothyronine sodium (CYTOMEL) for unknown indications from an unknown date. The patient had also received 3 allergy shots (unspecified) vaccine on 20Apr2021 in the left and right arm, for unknown indication. The patient previously received ciprofloxacin (CIPRO), levothyroxine (SYNTHROID), blue dye, almonds, sesame and latex for unknown indication on unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 14:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021, the patient experienced usual side effects of low-grade fever and fatigue for about 24-48 hours. On 02May2021, the patient experienced severe cramps. The patient was due for periods on 08May2021, but on 03May2021, the patient experienced early menstruation in addition to usual side effects of low-grade fever and fatigue. The clinical outcome of the events low grade fever, fatigue was recovered on an unknown date in 2021, while that of the event severe cramps and polymenorrhoea was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Vaccination site pain
Clinical narrative: Fatigue; chills; pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 20Apr2021 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and past drug. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 the patient experienced fatigue, chills and pain at injection site. The clinical outcome of the event fatigue, chills and pain at injection site was resolved on unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Malaise, Myalgia, Pyrexia
Clinical narrative: Fever; Achy muscles; Achy joints; Fatigue; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 02May2021 14:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), fenugreek, prenatal vitamins and loratadine (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior of vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 11Apr2021 at 14:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03May2021 at 01:00, 11 hours after the second dose of vaccination, the patient experienced fever, achy muscles, achy joints, fatigue and malaise. The clinical outcomes of the events fever, achy muscles, achy joints, fatigue and malaise was resolved on 04May2021 after lasting for about a day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Nasopharyngitis, Pain in extremity, Swelling
Clinical narrative: Entire back hurt; Left arm sore; Left armpit swollen a bit; Cold; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 03:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any concomitant medications within 2 weeks of vaccination. The patient previously took shellfish. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 00:15, the day after shot, the patient experienced that his entire back hurt, on a pain scale it was 6/10, had left arm sore, left armpit swollen a bit and cold most of the day. The clinical outcome of the events entire back hurt, left arm sore, left armpit swollen and cold was resolved on an unknown date on May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Severe body aches; Fever; Chills; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176), via an unspecified route of administration in the left arm on 29Apr2021 at 10:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included naproxen sodium (ALEVE) taken for an unspecified indication from an unknown date (was taken on occasion, none within 24 hours) and vitamin d nos (VITAMIN D) taken for an unspecified indication from an unknown date. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and sulfa drugs (MANUFACTURER UNKNOWN) for unknown indications on unspecified dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via an unspecified route of administration in the left arm on 08Apr2021 at 09:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 30Apr2021 at 01:30, the patient experienced severe body aches, fever, chills, headache and nausea which lasted approximately 18 hours. The clinical outcome of the events severe body aches, fever, chills, headache and nausea was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeds; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW967) via an unspecified route of administration in the left arm on 03May2021 at 10:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously had taken latex. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8374) via an unspecified route of administration in the right arm on 05Apr2021 at 10:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 12:00, the patient experienced nose bleeds . The clinical outcome of the event nose bleeds  was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Feeling abnormal, Headache, Myalgia
Clinical narrative: Vertigo; Diarrhea; Brain fog; Muscle pain; Headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0164) via an unspecified route of administration in the left arm  on 22Apr2021 at 15:15 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic kidney disease, dry eye, iritis and uveitis. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) of dose 180 milligram (mg), irbesartan (MANUFACTURER UNKNOWN) of dose 75 mg and valaciclovir (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications. The patient past drugs included paracetamol (TYLENOL), topiramate (TOPAMAX), penicillin (MANUFACTURER UNKNOWN), latex and cefalexin (KEFLEX). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 29Mar2021 at 16:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Apr2021, next day of vaccination, the patient experienced muscle pain and headache and on an unknown date in Apr2021, the patient experienced tiredness for three days then felt fine until brain fog started on 8th day after vaccination on 30Apr2021 at 12:00. On 02May2021, 10th day after vaccination, the patient experienced diarrhoea and on 03May2021, 11th day after vaccination, the patient experienced vertigo. The clinical outcome of the event tiredness was resolved on an unknown date in Apr2021 where as the outcomes of the events muscle pain, headache, brain fog, diarrhoea and vertigo were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; Diarrhea; Brain fog; Muscle pain; Headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0164) via an unspecified route of administration in the left arm  on 22Apr2021 at 15:15 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic kidney disease, dry eye, iritis and uveitis. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) of dose 180 milligram (mg), irbesartan (MANUFACTURER UNKNOWN) of dose 75 mg and valaciclovir (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications. The patient past drugs included paracetamol (TYLENOL), topiramate (TOPAMAX), penicillin (MANUFACTURER UNKNOWN), latex and cefalexin (KEFLEX). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 29Mar2021 at 16:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Apr2021, next day of vaccination, the patient experienced muscle pain and headache and on an unknown date in Apr2021, the patient experienced tiredness for three days then felt fine until brain fog started on 8th day after vaccination on 30Apr2021 at 12:00. On 02May2021, 10th day after vaccination, the patient experienced diarrhoea and on 03May2021, 11th day after vaccination, the patient experienced vertigo. The clinical outcome of the event tiredness was resolved on an unknown date in Apr2021 where as the outcomes of the events muscle pain, headache, brain fog, diarrhoea and vertigo were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Period was delayed 3 days past expected; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0162) via an unspecified route of administration in the right arm on 13Apr2021 at 11:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome and infertility. The patient had no known allergies. Concomitant medications included menotrophin (MENOPUR), OVASITOL, choriogonadotropin alfa (OVIDREL) and prenatal vitamins (MANUFACTURER UNKNOWN), etc. from an unknown date used for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the left arm on 25Mar2021 at 15:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient period was delayed three days past expected since patient knew ovulation day from ovidrel trigger. The clinical outcome of the event period was delayed was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.